Home > Balance Sheet > CONCORD BIOTECH

CONCORD BIOTECH
Total Non-Current Liabilities

    Back to Balance Sheet
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹32 Cr₹32 Cr₹54 Cr₹77 Cr₹55 Cr

What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?

The latest Total Non-Current Liabilities ratio of CONCORD BIOTECH is ₹32 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹32 Cr
Mar2023₹32 Cr
Mar2022₹54 Cr
Mar2021₹77 Cr
Mar2020₹55 Cr

How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹32 Cr
-0.71
Mar2023 ₹32 Cr
-40.93
Mar2022 ₹54 Cr
-29.74
Mar2021 ₹77 Cr
40.32
Mar2020 ₹55 Cr -

Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹20,800.2 Cr 2.1% -5.9% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,518.0 Cr -1.4% -7.1% 48% Stock Analytics
DIVIS LABORATORIES ₹158,636.0 Cr 1.5% -2.1% 63% Stock Analytics
CIPLA ₹118,368.0 Cr -3.5% -5.2% 18% Stock Analytics
DR REDDYS LABORATORIES ₹99,671.4 Cr -3.9% -10.1% 10.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,013.6 Cr -0.3% -7.3% 52.2% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

2.1%

-5.9%

40%

SENSEX

-2.4%

-4.2%

19.5%


You may also like the below Video Courses